Research Activities
The Immunocompromised Host Infectious Diseases group has a robust research platform. Multiple projects have been completed utilizing a collaborative transplant database. We also participate in both single center and multicenter retrospective studies. We are involved in clinical trials to advance the care of the immunocompromised patient population. Our team is involved in translational science, projects involving quality improvement, as well as studies of digital health platforms.
- A Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation (site PI: Epstein)
- An International Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Anti-Coronavirus Hyperimmune Intravenous Immunoglobulin for the Treatment of Adult Outpatients in Early Stages of COVID-19 (site PI: Subramanian, Co-PI Liu)
- A Phase 2 Randomized, Placebo-controlled Study of the Safety and Efficacy of Obeldesivir to Treat Nonhospitalized Adults With Acute Respiratory Syncytial Virus (RSV) Infection (site PI: Subramanian)